Cargando…

Differential expression of estrogen receptor subtypes in ovarian high‐grade serous carcinoma and clear cell carcinoma

PURPOSE: To investigate the role of estrogen receptors (ERs) in high‐grade serous carcinoma (HGSC) and clear cell carcinoma (CCC) of the ovary and evaluate ERs as prognostic biomarkers for ovarian cancer. METHODS: This study included 79 patients with HGSC (n = 38) or CCC (n = 41) treated at our inst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osaku, Daiken, Oishi, Tetsuro, Kawamura, Naoshi, Iida, Yuki, Komatsu, Hiroaki, Kudoh, Akiko, Chikumi, Jun, Sato, Shinya, Harada, Tasuku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499597/ https://www.ncbi.nlm.nih.gov/pubmed/34646075 http://dx.doi.org/10.1002/rmb2.12402

Ejemplares similares

Efficacy of panniculectomy-combined surgery in superobese patients with endometrial cancer: A case report and literature review
por: Okawa, Masayo, et al.
Publicado: (2020)

Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer
por: Nonaka, Michiko, et al.
Publicado: (2018)

Retroperitoneal Endometrioid Carcinoma Arising from Ureteral Endometriosis
por: Osaku, Daiken, et al.
Publicado: (2019)

Calcified Ovarian Fibromas Complicated with Basal Cell Nevus Syndrome
por: Osaku, Daiken, et al.
Publicado: (2021)

D-dimer level significance for deep vein thrombosis screening in the third trimester: a retrospective study
por: Miyamoto, Keisuke, et al.
Publicado: (2022)

AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk
por: Iida, Yuki, et al.
Publicado: (2023)

Oxidatively Modified Proteins in the Serous Subtype of Ovarian Carcinoma
por: Mehrabi, Sharifeh, et al.
Publicado: (2014)

Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma
por: Ma, Feng-Hua, et al.
Publicado: (2016)

Subtyping of high grade serous ovarian carcinoma: histopathological and immunohistochemical approach
por: Khashaba, Marwa, et al.
Publicado: (2022)

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea
por: Kim, Se Ik, et al.
Publicado: (2022)

A comparison of clinico-pathologic characteristics of patients with serous and clear cell carcinoma of the uterus
por: Üreyen, Işın, et al.
Publicado: (2016)

Prognostic Value of Peritoneal Cytology in Stage I Serous and Clear Cell Carcinoma of the Endometrium
por: Yang, Jie, et al.
Publicado: (2023)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
por: Lefebvre, Manon, et al.
Publicado: (2023)

Association of online activities with obstetrics and gynecology specialty choice: a nationwide online survey
por: Maeda, Yuto, et al.
Publicado: (2022)

Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
por: Gilks, C. Blake
Publicado: (2010)

Systematic Identification of Characteristic Genes of Ovarian Clear Cell Carcinoma Compared with High-Grade Serous Carcinoma Based on RNA-Sequencing
por: Nagasawa, Saya, et al.
Publicado: (2019)

Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
por: van der Ploeg, Phyllis, et al.
Publicado: (2021)

Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
por: Najjar, Omar, et al.
Publicado: (2020)

Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma
por: ZHANG, XINCHEN, et al.
Publicado: (2015)

Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
por: Shilpi, Arunima, et al.
Publicado: (2019)

The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
por: Romani, Chiara, et al.
Publicado: (2021)

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma
por: Hollis, Robert L., et al.
Publicado: (2023)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
por: Zhou, Huimei, et al.
Publicado: (2020)

Ovarian Large Cell Neuroendocrine Carcinoma Associated with Serous Carcinoma: Correlation of Pathology with MR Imaging
por: Takeuchi, Mayumi, et al.
Publicado: (2017)

Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
por: Czyzyk-Krzeska, Maria F., et al.
Publicado: (2021)

Impact of adenomyosis on perinatal outcomes: a large cohort study (JSOG database)
por: Komatsu, Hiroaki, et al.
Publicado: (2023)

Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta‐analysis of survival
por: Raffone, Antonio, et al.
Publicado: (2021)

Successful radiotherapy for endometrial serous carcinoma with local repeated recurrence
por: Kusumoto, Shinya, et al.
Publicado: (2018)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions
por: Furuya, Mitsuko, et al.
Publicado: (2016)

Comparison of Clinical Characteristic and Prognosis between Ovarian Clear Cell Carcinoma and Serous Carcinoma: A 10-Year Cohort Study of Chinese Patients
por: Ye, Shuang, et al.
Publicado: (2015)

Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
por: Wu, Peng, et al.
Publicado: (2018)

Glycogen rich clear cell carcinoma of the breast: a rare subtype with good prognosis
por: Al-Musaifer, Budoor Mohamed, et al.
Publicado: (2019)

Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma
por: Ding, Wencong, et al.
Publicado: (2023)

Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories
por: Pan, Xiu-wu, et al.
Publicado: (2023)

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2018)

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma
por: Itamochi, Hiroaki, et al.
Publicado: (2017)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs
por: Kitade, Shoko, et al.
Publicado: (2019)

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
por: Hamilton, C A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_um0jeec027d1nvkoli3rhcs549